Alexandria Forbes has served as MeiraGTx’s President, Chief Executive Officer and a member of the board of directors since March 2015. Prior to joining MeiraGTx, Dr Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015. Prior to Kadmon Holdings, Inc., Dr Forbes spent 11 years as a healthcare investor at Sivik Global Healthcare, a healthcare hedge fund, from September 2000 to November 2008, and at Meadowvale Asset Management, a healthcare hedge fund, from January 2010 to June 2012. Before entering the hedge fund industry, Dr Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center from March 1997 to September 2000. Prior to this, Dr Forbes was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University. Dr Forbes received an MA in Natural Sciences from Cambridge University and a PhD in Molecular Genetics from Oxford University.
